Highlights Implantica AG

Equities

IMP A SDB

SE0014855029

Delayed Nasdaq Stockholm Other stock markets 11:07:27 14/05/2024 BST			5-day change	1st Jan Change
27.25 ^SEK	+0.37%		+2.06%	+14.02%

04-26	Tranche Update on Implantica AG (OM:IMP A SDB)'s Equity Buyback Plan announced on April 6, 2023.	CI
03-27	Implantica Submits Initial Module of US FDA Premarket Approval Application for GERD Medical Device	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tranche Update on Implantica AG (OM:IMP A SDB)'s Equity Buyback Plan announced on April 6, 2023.	04-26	CI
Implantica Submits U.S. FDA Premarket Approval Application for RefluxStop® (first module)	03-27	CI
Implantica Completes Human Factors Validation Study for RefluxStop as Part of the US FDA Premarket Approval Process	03-26	CI
Implantica to Deploy GERD Treatment in Spain	03-19	MT
Implantica AG (publ.) Wins Another RefluxStop Public Tender in Europe with Hospital Universitario De Getafe	03-19	CI
Implantica AG (OM:IMP A SDB) acquired IRCCS Saverio De Bellis.	03-04	CI
Implantica AG Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-16	CI
Implantica Announces Completion of its First RefluxStop Procedures at Artemed Klinikum München Süd in Munich, Germany	02-15	CI
Implantica Announces First Refluxstop Public Tender Win, Paving the Way for Permanent Reimbursement in Italy	02-13	CI
Implantica Ag Announces the First RefluxStop Procedures Completed At MIC Hospital in Berlin	02-06	CI
Implantica AG (publ.) Adds Another RefluxStop Center in Spain	12-18	CI
Implantica AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-22	CI
Implantica AG (publ.)'s RefluxStop Offers for the First Time in the NHS in UK	11-21	CI
Implantica Wins EU Medical Device Certifications	07/09/23	MT
Implantica AG Receives MDR Certification for RefluxStop?	07/09/23	CI
Implantica AG Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	24/08/23	CI
Implantica AG Further Expands Its Commercial Footprint in Italy	29/06/23	CI
Implantica AG Announces RefluxStop Results Were Presented At the DDW Conference in Chicago	16/05/23	CI
Tranche Update on Implantica AG (OM:IMP A SDB)'s Equity Buyback Plan announced on April 6, 2023.	12/05/23	CI
Implantica AG Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Implantica AG

Equities

IMP A SDB

SE0014855029

Highlights

Filters